All 10 drug companies whose drugs were selected for drug price negotiation with the Medicare program have elected to participate in negotiations.
President Joe Biden made the announcement on Tuesday in an online video. The first 10 companies were announced by the Centers for Medicare and Medicaid Services (CMS) in August and gave the...
Last week, the Southern District Court of Ohio heard the first oral arguments from the U.S. Chamber of Commerce (CoC, the Chamber) and the U.S. Department of Justice (DOJ). The Chamber requested an injunction of the Medicare negotiation program before October 1, which is the deadline for companies to sign an agreement to participate in...
The Biden administration released revised guidance for the Medicare drug price negotiation program late last week in response to the mounting lawsuits against the policy required by the Inflation Reduction Act (IRA) of 2022.
Drugmakers Merck and Bristol Myers Squibb, as well as industry representatives like the U.S. Chamber of...
Pharmaceutical industry advocacy organizations including the Pharmaceutical Research and Manufacturers of America (PhRMA) and a third drug manufacturer have sued the federal government over the provision of the Inflation Reduction Act (IRA) that allowed for Medicare drug price negotiation for select pharmaceuticals.
Pharmaceutical...
The U.S. Chamber of Commerce has filed suit against the federal government, challenging the Medicare drug price negotiation program.
The lawsuit is the second of an expected many against the new program which was authorized by the Inflation Reduction Act last summer. The Chamber of Commerce, which refers to itself as the "world's...
